Assertio Holdings Engages in Healthcare Virtual Summit 2024
LAKE FOREST, Ill. — Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a forward-thinking pharmaceutical company, is excited to announce that its Chief Executive Officer, Brendan O’Grady, will be part of the Maxim Group 2024 Healthcare Virtual Summit. O'Grady will engage in an insightful fireside chat discussion, moderated by Naz Rahman, a research analyst with Maxim Group.
Event Details
The engaging conversation is scheduled for Tuesday, October 15, 2024, at 1:00 PM Eastern Time. This event represents a remarkable opportunity for investors and industry professionals alike, as it offers a platform to delve deeper into the strategic initiatives and innovative solutions that Assertio is dedicated to providing.
Event Participation
This summit is designed to connect healthcare thought leaders and innovators, allowing them to share insights and discuss trends shaping the future of pharmaceuticals. Assertio, known for its commitment to developing differentiated products, is eager to contribute to this important discussion.
About Assertio
Assertio is not just a pharmaceutical company; it is a hub for commercial excellence in the healthcare industry. Assertio has developed a robust portfolio through thoughtful acquisitions and partnerships, focusing on approved products that meet the diverse needs of patients. Their strategic marketing efforts blend a dedicated sales force with innovative non-personal promotion techniques, ensuring the reach and effectiveness of their product offerings.
Commercial Capabilities
With strong market access strategies, Assertio engages in effective payor contracting and sophisticated distribution channels. This multi-faceted approach allows the company to effectively connect with healthcare providers and patients, ensuring that vital medications are accessible to those who need them most.
Investor Information
Stakeholders and interested parties can gain additional insights into Assertio’s strategic direction and offerings by participating in this engaging summit. For further inquiries about the company, investors are encouraged to reach out directly.
Contact for Investors
Matt Kreps, Managing Director
Darrow Associates
M: 214-597-8200
Email: mkreps@darrowir.com
Frequently Asked Questions
What is the purpose of the Maxim Group Healthcare Virtual Summit?
The summit aims to connect innovators, industry leaders, and investors in the healthcare space to discuss advancements and trends in the pharmaceutical industry.
Who will be representing Assertio at the summit?
Brendan O’Grady, the Chief Executive Officer of Assertio Holdings, will be participating in the fireside chat during the event.
What are Assertio's main commercial capabilities?
Assertio excels in marketing and distribution with a mix of personal sales and non-personal promotion, alongside effective payor contracting.
How can investors learn more about Assertio's offerings?
Investors can engage with the company during the summit and reach out directly for further information.
Where can I find more information about Assertio?
To learn more about Assertio's products and corporate strategy, visit their official website at www.assertiotx.com.
